- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED Jun 12, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,581 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NEWBRY | kr3.36 | 14.3% | -5.9% | kr81.5m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €8.35 | -2.9% | n/a | €118.0m | €9.70 | PS20.3x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
GAU | CA$2.15 | -6.1% | 186.7% | CA$538.8m | CA$2.82 | PE31x | E41.1% | n/a | Materials | ||
ARES | US$137.49 | -1.5% | 46.0% | US$42.1b | US$150.73 | PE62.2x | E29.7% | 2.7% | Diversified Financials | ||
GIG | kr31.25 | -2.0% | 22.5% | kr4.2b | kr45.03 | PE19.5x | E36.2% | n/a | Consumer Services | ||
AXSM | US$71.55 | -3.4% | -11.6% | US$3.4b | US$123.75 | PS13.5x | E64.1% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$21.57 | -2.4% | 23.8% | US$2.3b | US$26.82 | PE18.2x | E48.9% | 3.9% | Energy | ||
MVW | kr8.00 | -2.4% | 21.2% | kr256.8m | kr12.00 | PS24.1x | E69.0% | n/a | Materials | ||
CADLR | kr62.60 | -4.0% | 29.6% | kr21.8b | kr73.36 | PS17.7x | E62.4% | n/a | Capital Goods | ||
VOW | kr6.83 | 2.2% | -48.5% | kr750.2m | kr11.00 | PB2x | E97.6% | 0% | Commercial Services | ||
AGP | €7.65 | -3.2% | 114.9% | €131.4m | €12.75 | PE26.9x | E22.8% | n/a | Capital Goods | ||
MBTN | CHF0.0073 | -9.9% | -98.7% | CHF168.5m | n/a | PS1.3x | E82.0% | n/a | Semiconductors | ||
OSE | €7.22 | -3.5% | 113.3% | €156.5m | €7.15 | PS70.4x | E79.3% | n/a | Pharmaceuticals & Biotech | ||
FDE | €34.35 | -4.8% | -26.8% | €178.4m | €64.07 | PE22.9x | E37.7% | n/a | Energy | ||
CRDO | US$29.08 | 9.7% | 64.3% | US$4.7b | US$27.83 | PS24.6x | E84.1% | n/a | Semiconductors | ||
CALTX | kr205.60 | -1.1% | 115.6% | kr11.1b | kr221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$16.81 | 1.7% | -38.2% | US$2.3b | US$31.50 | PE58.4x | E48.0% | n/a | Pharmaceuticals & Biotech | ||
FWRY | ج.م5.59 | -2.6% | -7.8% | ج.م19.1b | ج.م8.17 | PE23.8x | E33.0% | n/a | Diversified Financials | ||
KEBNI B | kr1.67 | 7.3% | 36.3% | kr444.2m | kr2.20 | PS4.9x | E90.4% | n/a | Tech | ||
GGP | UK£0.072 | -2.0% | 10.3% | UK£373.6m | n/a | PB7.3x | E62.1% | n/a | Materials | ||
ERO | CA$28.68 | 7.1% | 5.8% | CA$2.9b | CA$33.83 | PE35x | E60.1% | n/a | Materials | ||
DIRR3 | R$25.70 | -2.5% | 36.2% | R$4.5b | R$29.73 | PE10.5x | E20.4% | 1.8% | Consumer Durables | ||
NVDA | US$125.20 | 2.3% | 191.2% | US$3.0t | US$124.33 | PE72.2x | E22.6% | 0.01% | Semiconductors | ||
A178320 | ₩29,350.00 | 1.0% | 64.9% | ₩1.6t | ₩36,666.67 | PE151.9x | E48.1% | 0% | Tech |